anavex.com - Nilai perusahaan marang volume dodolan AVXL

anavex.com (AVXL) - logo korporat

The foundation of Anavex Life Sciences (AVXL) growth is its independence from market cycles and its focus on FDA approval. The EV/Sales ratio confirms this trend, with the current level sitting around 0.00. High authority in neuromedicine strengthens the brand's position, while preparations for drug commercialization ensure future business scalability, despite temporary costs associated with expanding clinical bases.

Anavex Life Sciences Corp (AVXL): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Anavex Life Sciences Corp - rincian analitis lan metrik utama (AVXL)

- rincian nilai pasar emiten:
Pambiji fundamental perusahaan:AVXL (Anavex Life Sciences)
Produk asli Anavex Corp

This indicator compares the total enterprise value to sales volume, excluding the impact of debt load to determine the net market valuation. Analyzing this ratio allows an investor to identify an overbought asset and minimize risks when assessing fundamental value. The EV/Sales multiple history clearly demonstrates capitalization dynamics relative to actual revenues. For Anavex Life Sciences (AVXL), this metric reflects market expectations regarding the success of clinical trials for CNS disease drugs. The efficiency of management's unique developments directly determines the future attractiveness of this metric.

Analisis pesaing Anavex Life Sciences

BIIB (Biogen Inc.) - Rasio nilai perusahaan marang pendapatan|NBIX: Multiplikator EV/Sales|RGC (Regencell Bioscience Holdings Limited) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Axsome Therapeutics Inc|ACAD: Nilai bisnis marang pendapatan|Multiplikator EV/Sales XENE|Multiplikator EV/Sales vikingtherapeutics.com (VKTX)|Rasio nilai perusahaan marang pendapatan Supernus SUPN|Nilai bisnis marang pendapatan CPRX|denalitherapeutics.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Harmony Pharma HRMY|BHVN: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PRAX (Praxis Medicines)|Rasio nilai perusahaan marang pendapatan CeriBell Corp (CBLL)|Koefisien nilai perusahaan marang pendapatan PRTA|Multiplikator EV/Sales ALEC (Alector)|Annexon (ANNX) - Multiplikator nilai perusahaan marang pendapatan|OMER - Rasio nilai perusahaan marang pendapatan|NGNE (Neurogene) - Rasio nilai perusahaan marang pendapatan|ACIU: Multiplikator EV/Sales|VYGR - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Neumora Therapeutics, Inc.|Rasio nilai perusahaan marang pendapatan SCLX (Scilex)|Nilai perusahaan marang pendapatan TVGN (Tevogen Bio)|Multiplikator EV/Sales Alpha Cognition Inc (ACOG)|Multiplikator EV/Sales CGTX (cogrx.com)|Rasio total nilai perusahaan marang pendapatan Inhibikase Pharma (IKT)|SAVA: Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Assertio ASRT|COYA (coyatherapeutics.com) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan VTGN|OVID (Ovid Therapeutics) - Multiplikator EV/Sales|Acumen Pharmaceuticals, Inc (ABOS) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan CervoMed, Inc. (CRVO)|ATHE - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales CLNN (Clene Inc.)|Rasio total nilai perusahaan marang pendapatan PepGen Inc. (PEPG)|JUNS - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Relmada Corp|ANVS (Annovis Bio, Inc.) - Nilai perusahaan marang pendapatan|Grace Tx (GRCE) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan AIFF|Multiplikator EV/Sales anewmeds.com|Rasio nilai perusahaan marang pendapatan NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Nilai bisnis marang pendapatan|MetaVia - Nilai perusahaan marang pendapatan|NRXS: Rasio nilai perusahaan marang pendapatan|Helius Medical Technologies, Inc. - Multiplikator EV/Sales|PASG: Rasio nilai perusahaan marang pendapatan|Neuphoria (NEUP) - Rasio nilai perusahaan marang pendapatan|Minerva Neurosciences - Nilai bisnis marang pendapatan|ATHA (Athira Pharma, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan addextherapeutics.com ADXN|Nilai perusahaan marang pendapatan ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales PTIX (Protagenic)|Multiplikator EV/Sales pasitheaclinics.com KTTA|CRGT - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ATXI (Avenue Therapeutics)|BCLI: Multiplikator EV/Sales|Cara Therapeutics - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Chromocell Therapeutics Corporation|Multiplikator EV/Sales Eliem Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales MRNS (marinuspharma.com)|NKGN: Rasio nilai perusahaan marang pendapatan|NRBO - Rasio nilai perusahaan marang pendapatan|SAGE - Multiplikator EV/Sales|Synaptogenix (SNPX) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Trevena (TRVN)|Nilai perusahaan marang pendapatan VIGL|Rasio nilai perusahaan marang pendapatan WENA (Anew Medical)|Multiplikator EV/Sales CERE